Skip to main content
EVAX
NASDAQ Life Sciences

Evaxion Posts $3.7M Q2 Loss, Cash Runway Into 2027; EVX-04 Filing Set for Year-End

Tom Rudovsky · Reported by Dow Jones Newswires
More coverage: Biotech Stocks · Healthcare
Sentiment info
Neutral
Importance info
7
Price
$3.475
Mkt Cap
$26.272M
52W Low
$2.52
52W High
$12.15
52W Position info
38% above low
Off High info
71% below high
Rel. Volume info
52× avg
Market data snapshot near publication time

EVAX sits 38% above its 52-week low of $2.52 on elevated volume (52× avg).

Summary

Evaxion reported Q2 2026 net loss of $3.7 million, slightly wider than Q1's $3.6 million but narrower than the $4.8 million loss a year ago, with the narrowing attributed to lower expenses. Cash and equivalents fell to $14.0 million from $18.4 million at end of Q1, but management reiterated runway into the second half of 2027. The company also confirmed it expects to submit the regulatory filing for its EVX-04 AML vaccine candidate before year-end and plans to expand into autoimmune disease programs in H2 2026. The update follows a series of positive pipeline announcements, including the new EVX-05 glioblastoma program with Duke and upcoming three-year EVX-01 data at ESMO in October. With a market cap around $26 million, the cash position and runway are critical; the reiterated guidance and near-term catalysts keep this on traders' radar.

At the time of this announcement, EVAX was trading at $3.48 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $26.3M. The 52-week trading range was $2.52 to $12.15. This news item was assessed with neutral market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.


Price Chart

Share this article

Copied!

EVAX - Latest Insights

EVAX
Nov 19, 2026, 7:05 AM EST
Filing Type: 6-K
Importance Score:
7
Price at Filing: $2.54
Real-time Price: $2.32 info
Change: -$0.2241 (-9%) info
Market Cap: $18.765M info
EVAX
Nov 19, 2026, 7:00 AM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $2.82
Real-time Price: $2.32 info
Change: -$0.5035 (-18%) info
Market Cap: $18.765M info
EVAX
Oct 23, 2026, 6:00 AM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $4.04
Real-time Price: $2.32 info
Change: -$1.72 (-43%) info
Market Cap: $18.765M info
EVAX
Oct 19, 2026, 3:00 AM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $3.25
Real-time Price: $2.32 info
Change: -$0.9341 (-29%) info
Market Cap: $18.765M info
EVAX
Aug 20, 2026, 7:30 AM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $3.47
Real-time Price: $2.32 info
Change: -$1.15 (-33%) info
Market Cap: $18.765M info